About Me
Dr. Ginn's clinical focus is in the care of pediatric patients with central nervous system tumors. He directs the multi-disciplinary team at Children's Mercy providing care for approximately 50 brain and spine cord tumors a year. His current primary research role is as Interim Director of the Experimental Therapeutics in Pediatric Oncology Program. Dr. Ginn is a site Principal Investigator for approximately 30 early phase clinical trials. His team participates in Children's Oncology Group, Beat Childhood Cancer, Aflac Cancer Center and Industry Sponsored clinical trials. They also provide support to local Oncologist regarding expanded access to investigational agents and provide support for local investigator initiated trials. He is interested in expanding collaborations and bringing more local investigator trials through to completion.